MIR4509-2

Across TCGA pan-cancer cohorts, MIR4509-2 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR4509-2 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR4509-2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4509-2 expression acts as an unfavorable survival marker.

STAD and SKCM are the cancer types where MIR4509-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.122	0.660	<.001	108	view →
SKCM	OS	Tertile	All	0.150	0.787	<.001	72	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR4509-2–STAD (DFS)

Open the STAD breakdown →